Overview

A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Data suggests that imaging activity of the brain can measure the effects of anti-anxiety drugs. This study will investigate the effect of GW876008 on areas of the brain involved with thinking and emotion
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Lorazepam